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Anti-cancer action of metal complexes: electron 
transfer and oxidative stress? 
P. Kovacic 1, W.J. Popp1, J.R. Ames1 & M.D. Ryan2 
'Department of Chemistry, University of Wisconsin-Milwaukee, Milwaukee. Wisconsin 53201. 
and 2Department of Chemistry. Marquette University. Milwaukee, Wisconsin 53233, USA 
Summary: Evidence is presented in support of an electron transfer mechanism for various metal 
complexes possessing anti-neoplastic properties. Cyclic voltammetry was performed on several 
metallocenes, his(acetato)bis(imidazole)Cu(II), and coordination compounds (Cu or Fe) of the anti-
tumor agents, bipyridine, phenanthrolinc, hydroxyurea, diethyldithiocarbamatc, and a,a'-bis(S-
hydroxyquinolin-7-yl)-4-methoxytoluene. The favorable reduction potentials ranged from + 0.5 to 
-0.5 V. Electrochemical behavior is correlated in some cases with structure and physiological 
activity. Relevant literature data are discussed. 
Although the mechanisms by which xcnobiotics 
operate are becoming better understood, many 
questions still remain. Several decades ago, the 
hypothesis was advanced that oxygen radical 
entities play an important role in the cancer 
process (Brues & Guzman Barron, 1951; Har-
man, 1956, 1962; Holman, 1956; Kovacic, 1959, 
1960). These moieties can attack cellular consti-
tuents, e.g. DNA, resulting in transformations 
that may give rise to the oncogenic state. At 
about the same time, oxy radicals were sug-
gested to play a major role in anti-cancer action 
(Holman, 1956; Kovacic, 1959). These concepts 
have received recent support (Kovacic et a/., 
1986; Oberley & Buettner, 1979; Lawn, 1985). 
Many carcinogens display anti-cancer action 
and vice versa (Kovacic et at .• 1986). Reactive 
oxygen species seem to be implicated in both 
cases. Indeed, certain tumor cells are more sensi-
tive than normal ones to elevated concentrations 
of oxy radicals (Kovacic, 1959; Oberley & 
Buettner, 1979). 
The basic scheme entails abstraction of elec-
trons from cellular material by a catalytic elec-
tron transfer (ET) agent bound to the active site. 
The oxy radicals produced by conveyance of 
electrons to oxygen then attack vital cellular 
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components. In some cases, ET may result in 
interference with normal electronic processes. 
The principal categories of ET agents arc metal 
complexes, quinoncs, ArN02• iminium ions, 
aromatic azo compounds, and llavins. It has 
been shown that many anti-cancer agents fit into 
these classifications (Kovacic eta/., 1986; Kava· 
cic et at .• 1987a; Kovacic et a/., 1988a; Kovacic 
et a/., 1988b; Kovacic et a/., 1988t). Metal 
species produce a number of responses in bio-
logical systems relevant to the present discus-
sion, namely oxygen radical generation (Ames, 
1983; Kovacic eta/., 1986; Czapski & Goldstein, 
1987), DNA strand cleavage (Furst & Radding, 
1984; Czapski & Goldstein, 1987), and DNA 
complex formation (Furst & Radding, 1984; 
Saenger, 1984). Moreover, ET has been sug-
gested to play an important mechanistic role 
(Lumme & Elo, 1985; Czapski & Goldstein, 
1987). 
The objective of this work was to ascertain the 
electrochemical characteristics or various drugs 
belonging to the metal category of anti-cancer 
agents. Cobaltocenium hexalluorophosphate 
(Cp2CoPF6), ruthcnocenc (Cp,Ru), nickelocene 
(Cp2Ni), titanocene dichloride (Cp2TiC12), and 
his(acetato)bis- (imidazole)copper (ll) [Cu(OAc)2 (Hlm)2] were investigated. The anti-tumor 
agents, bipyridine (bipy), o-phenanthroline 
(phen), hydroxyurea (HU). diethyldithiocarba-
~:C The Macmillan Press Ltd, 1988 
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mate (DOC), and a, a' -bis(8-hydroxyquinolin-
7-yl)-4-methoxytoluene were examined in the 
form of their metal complexes (Fe or Cu). 
Materials and methods 
The metal complexes, Cu(phen)2(N03) 2 (Faye, 
1966), and Cu(bipy)2(N03) 2 (Hathaway et a/., 
1969) were prepared by literature methods; ele-
mental analyses were satisfactory. The 8-hy-
droxyquinoline derivative, I was synthesized by 
the method of Yamato eta/. (1987) except that 
solvent was omitted. The n.m.r. spectrum 
matched that reported; elemental analysis was 
satisfactory; mass spectrum, (Cl), 409 
(M+ + 1)(100%). However, the m.p. (148-
150oC) disagreed with the reported value of 200-
203oC; this may be due to the presence of 
structural isomers. 
For complexes prepared in solution (Cu 
(bipy),(NO,),, Cu(HU),(N03) 2, Fe(HU)Cl3, 
FeCl,·DDC(l:l), Cu(N03) 2·DDC(l:l), FeCI3·1 (2:1); and [Cu(0Ac),(Hlm)2]), the precursors 
were allowed to react for 30 min before electro-
chemical measurements were performed. The 
Fe(HU)Cl3 solutions were generated in dime-
thylformamide due to instability of the complex 
under aqueous conditions (Harman eta/., 1970). 
An aqueous ethanolic solution of bis(acetato) 
bis(imidazole)copper(II) reduced with an £1 of 
0.36 V. Copper(II) acetate reduced with adsorp-
tion at 0.17V. 
Metallocenes and ligands were obtained from 
Aldrich Chemical Co.; other reagents and elec-
trochemical procedures have been previously 
reported (Ames et a/., 1987a; Crawford et a/., 
1986; Kovacic et a/., 1987b). A platinum flag 
(7 x 9 mm) was used as the working electrode. 
All values reported are versus NHE (SCE values 
adjusted by 0.24 V) at a scan rate of 100 mY /s. 
Results and discussion 
Metallocenes 
Metallocenes and metallocene dihalides exhibit 
anti-tumor activity (Kopf-Maier et a/., 1980; 
Kopf-Maier et a/., 198la and b; Kopf-Maier, 
1985; Kopf-Maier et a/., 1985), the degree of 
which is highly dependent on the transition 
metal (Kopf-Maier et at., 198la). The most 
effective compounds, which have received the 
most attention, are the dihalides whose activities 
are comparable to that of cis-platin (Kopf-
Maier et a/., 198la). The hypothesis has been 
advanced that metallocenes exert their action by 
a mechanism similar to the cis-platin case 
(Kopf-Maier and Kopf, 1980) in which the 
compound in the blood exists as a neutral mol-
ecule that is able to penetrate the cell membrane 
by passive diffusion (Dombrowski et a/., 1986). 
Chloride ion concentration inside the cell is very 
low compared to that in blood. Therefore, as the 
agent enters the cell it undergoes aqueous dis-
sociation of the halide to produce a positively 
charged species that can react with nucleophilic 
sites located in the cell. 
The transition metal is fundamental to the 
activity of these compounds, due in part to 
complexation with DNA. It is essential that the 
coordination geometry or 'bite' of the agent fits 
the site of attack on the helix (Kopf-Maier eta/., 
198lb). Guanosine residues may be the binding 
entities, since they serve in this capacity for 
related species (Tamura eta/., 1987). The result-
ing coordination compound may subsequently 
participate in ET. Hence, it is reasonable that 
the electrochemical characteristics of the met-
allocenes may also play a major role. 
Table I lists the reduction potentials of 
various metallocenes. All of the active com-
pounds reduced in the favorable range of + 0.40 
to -0.44 V, based on the present work and 
literature data. The most potent anti-tumor 
agents are Cp2TiCI2, Cp2TiBr2, Cp2VCI2 and 
Cp,NbBr, (Kopf-Maier and Kopf, 1980; Kopf-
Maier et ·a/., 1981 a and b). A lower level of 
activity is exhibited by Cp,Fe+ (Kopf-Maier, 
1985). Cp2ZrBr3, which has no anti-tumor 
action (Kopf-Maier et a/., 1980), does not re-
duce in an aqueous medium. No information 
was found concerning the activities of 
Cp2CoPF6, Cp2Ni, and Cp,Ru. Cp2TaBr3, which 
is not chemically reducible, shows sporadic anti-
tumor effects (Kopf-Maier et a/., 198lb). 
Although there is some correlation between 
reduction potential and activity, exceptions are 
seen. It is reasonable to expect important invol-
vement of other factors also. 
Bis ( acetato) bis( imidazole) copper( II) 
Recently, bis(acetato)bis(imidazole)copper(II), 
r 
! 
t 
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Table I Reduction values for metallocenes and metallocene halidesa 
Compound 
Cp,TiCI, 
Cp,TiBr, 
Cp,VCI, 
Cp,NbBr, 
Cp2TaBr3 
Cp2ZrBr3 
Cp,CoPF, 
Cp,Fe-
Cp2Ni 
Cp,Ru 
Reduction values 
80% EtOH (E,) H,O (E1) 
-0.44 
NR 
+0.01 
NR 
-0.29" 
-0.17" 
- 0.29"',- 0.56"·' 
NR" 
NR" 
+0.40' 
'Scouting experiments in DMF gave appreciably more negative values for 
Cp,TiCI2, but more positive for Cp2Ni 
~wilkinson and Birmingham, 1954 
'In NaCI04 solution 
dJn HC104 solution 
<Reversible value from Cp2Fe oxidation (Gagne eta!., 1980) 
[Cu(OAc),(Hlm),)], was found to possess strong 
anti-tumor activity (Tamura et al., I 987). From 
cyclic voltammetry, the reduction potential of 
the complex in aqueous ethanol was 0.36 V with 
a difference in cathodic and anodic peak poten-
tials of 160 mV; the reaction was 100% rever-
sible. Alone, Cu(0Ac)2 reduced at E, ~ 0.17 V 
with adsorption. It is evident that imidazole 
favorably influences conversion of Cu(II) to 
Cu(l). Prior investigators found a value of 
0.32 V as the E*r for an aqueous copper(II) 
imidazole complex (James & Williams, 1961). 
Studies with the restriction enzyme Ban I 
indicate that [Cu(OAc),(Him),] binds to the 
guanosine residues of DNA (Tamura et al., 
1987). The resulting metal purine coordination 
compound may be capable of redox chemistry 
leading to generation of oxy radicals in a site-
specific manner, analogous to related xenobio-
tics (Bachur et al., I 982; Barton, 1986). [Cu(OA-
c)2(Hlm)2] is comparable in cytoxicity to cis-
platin and superior to mitomycin C (Tamura et 
a/., 1987), which are believed to participate in 
ET reactions (Kovacic et al., I 986). This com-
plex has been examined as a model for the redox 
couple in copper proteins (Henriksson et a!., 
1976; Henriksson, 1977). 
Metal chelators 
Bipyridine and phenanthroline The chelating 
agents 2,2'-bipyridine, (bipy) and o-phenanthro-
line, (phen), as well as derivatives, are antineo-
plastic (Letier et al., I 953; Dwyer et a/., 1965; 
Mayhew et al., 1965; Shulman et al., 1977). It is 
likely that these agents exert their activity via 
complexation with metals such as copper or 
iron. Although coordination with iron is more 
likely due to the larger in vivo pool, o-phenan-
throline has been observed to complex with Cu 
in several tissues (Gutteridge, 1984). Our discus-
sion will mainly involve Cu, the metal most 
widely studied. 
The electrochemical behavior of complexes 
of bipy and phen were determined. 
Cu(phen)2(N03) 2 reduced in a quasi-reversible 
manner with £ 1 of 0.34 V and 6£ of 105 mV (Table II). The reaction was diffusio~ controlled 
with an i,)ili' value slightly larger than one (I. I). 
The ratio ot the current function (CF) (benzil as 
reference) (Ryan & Evans, 1976) was 0.59, indi-
cating the transfer of one electron. The small 
value of the ratio is due to the lower diffusion 
coefficient expected for the cation. The complex 
was not studied in aqueous ethanol due to 
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Table II Cyclic voltammetry of metal complexes from bipy and phena 
Compound E1 (V) 6E, (mV) 
Cu(phen),(NO,), 0.34,,, 105 
Cu(bipy),(NO,), 0.30 130 
0.22" 100 
Cu(NO,);bipy (1:2) 0.21" 130 
•JOO m Vis. compound (0.5 mM), electrolyte (0.1 M). PI electrode versus SCE, 
adjusted to NHE, DMF unless otherwise indicated 
h50% aqueous ethanol 
'Insoluble 
reduced solubility. A value of about 0.17 V has 
been reported under aqueous conditions (Ogura 
& Arinobu, 1978; Albert, 1979a; Koppenol, 
1987). 
The possibility of redox cycling in vivo is 
supported by involvement of NADH (Reich et 
a/., 1981) (£'' = -0.32 V (Rawn, 1983) ), thiols 
(Downey et al., 1980; Gutteridge & Halliwell, 
1982), or ascorbate (Chiou, 1984) in DNA scis-
sion by phenanthroline chelates of copper. The 
autoxidation involving thiols generates oxy 
radicals (Downey et a/., 1980; Marshall et a/., 
1981). The different reactivities of various metal 
complexes may be reflective of the different 
redox potentials (Chiou, 1984). The cupric com-
plex inhibits polymerase activity which may be 
related to its ability to cleave DNA and generate 
toxic oxy species (Sigman et a/., 1979); the 
reaction is blocked by catalase. The Cu·2,9-
dimethylphenanthroline adduct, £ 1 = 0.88 V (Patterson & Holm, 1975), does not cleave DNA 
(Reich et a/., 1981). This may be due to the 
absence of redox cycling resulting from steric 
interactions (Sigman, 1986). 
The Cu(3,4, 7 ,8-tetramethylphenanthroline )2 
cation exhibits anti-tumor properties (Dwyer et 
a/., 1965; Mayhew et a/., 1965). A reduction 
value slightly less than 0.34 V is expected as a 
result of the alkyl substituents (Albert, 1985; 
Ames et a/., 1986a). 
Ruthenium(II) tetramethylphenanthroline 
complexes are also effective against tumors 
(Dwyer et a/., 1965; Mayhew et al., 1965). The 
stability of the cations suggests that their bio-
logical effects are due to the complex as a whole 
rather than the individual constituents from 
dissociation (Dwyer et a/., 1965). The complex 
cleaves DNA upon irradiation (Mei & Barton, 
1986). Recently, Clarke eta/. (1986) proposed 
that Ru(ll) ammine complexes with DNA may 
exert their activity by redox cycling in the pres-
ence of oxygen and a reducing agent, producing 
active oxygen species which cleave the polymer. 
The bipy copper species behaved in a manner 
analogous to the phen counterparts in DMF. 
The £ 1 was 0.30 V with E v!2 = 130m V and 
current ratio of0.97 (Table IIJ. One electron was 
involved (see above), CF ratio = 0.79. The 
difference in E, values (40mV) for the phen 
versus the bipy complexes in our work is similar 
to a reported value (50 m V) under aqueous 
conditions (Albert, 1979a; Koppenol, 1987). 
In aqueous ethanol Cu(bipy),(NO,), took up 
an electron at 0.22 V. Again, the reaction was 
diffusion controlled and quasi-reversible 
(6Ev = IOOmV; iv,fi"' = 0.92) (Table II). We 
also investigated the complex formed in situ 
(E, = 0.20 V). Prior studies have found a value 
o(O.I2 V in neutral solution (Albert, 1979a). 
In the presence of oxygen and a reducing 
agent the complexes from bipy and phen gener-
ate superoxide (Graham et a/., 1980). Phen 
chelates are generally more potent than corre-
sponding bipy compounds against leukemia 
(Shulman et a/., 1977), as in the anti-bacterial 
realm (Albert, 1979a), and they also possess 
more positive reduction potentials (Table II and 
Albert, 1979a). Phenanthroline chelates of 
Ru(II) may interfere with biological redox reac- : 
lions (Dwyer eta/., 1969). 
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Hydroxyurea Hydroxyurea is very active 
against LI210 lymphoid leukemia, and is a 
metal binder (Harmon et a/., 1970; Berger & 
fritz, 1972; Albert, 1979b). Metal chelation may 
correlate with biological activity. The molecular 
basis for its selectivity is attributed to the seques-
tering of iron required by the iron-dependent 
enzyme ribonucleoside diphosphate reductase 
(Albert, 1979b). In line with our general prem-
ise, we studied the redox properties of solutions 
containing HU and iron(III) ·or copper(II). The 
results are summarized in Table Ill. 
The Fe(Ill)·HU (1:1) solution gave quasi-
reversible reduction at 0.31 Y in DMF with an 
average separation of 180m Y between the cath-
odic and anodic peaks; this solvent was chosen 
because of instability of the complex under 
aqueous conditions (Harmon et a/., 1970). The 
process was 83% reversible (i Ji" x 100%). 
Changing the solvent to ethanofJDMF (75/25) 
_resulted in an anodic shift of the first peak to 
£1 = 0.56 V. The reaction was more reversible With 6£, and i,ji"' of 140 mY and 1.0, respecti-
:vely; HU did not reduce before the background 
-discharge. In the case of iron, the in situ com-
plexes reduced at the same potential as FeCI1 in 
the solvents used. However, the solutions that 
contained both FeCI1 and HU were dark green 
as reported for other non-aqueous systems 
(Harmon et a/., 1970), whereas the solutions 
with iron alone were yellow. 
Complexation with copper (I :2) (Harmon et 
a/., 1970) in aqueous ethanol produced an irre-
versible (£, 12 = 140 mY) reaction at 0.30 Y. 
Chelation brings about an increase of 0.1 Y in 
the reduction potential of the metal (Table III). 
HU gave no reduction before -0.2 Y. A pre-
vious study reported an£\ value of -0.5 Y at 
pH 6.8 (Wold eta/., 1980). 
The involvement of HU in radical reactions is 
reasonable since the cytotoxic effects are less-
ened by radical scavengers, e.g. SOD, a-toco-
pherol, and ascorbic acid (Przybyszewski & 
Malec, 1982; Szczepannska et a/., 1985). Pre-
liminary experiments indicate that the terato-
genic activity ofHU may result from the genera-
tion of oxy radicals (De Sesso, 1979). H U 
exhibits electron carrier properties by acting as a 
conduit between NADH and oxygen with 
reduction of nitroblue tetrazolium. SOD in-
Table III Voltammctry of metal complexes from HU, DDC, and 1" 
Solution E1 (V) 6E, (mV) 
Fe(lll)·HU (1:1) 0.31 180 
0.56" 140 
Cu(li)·HU (1:2) 0.30' 140 
Fe( III)· DOC (I :I) - 0.20" 70 
Cu(li)·DDC (1:1) -0.49 100 
Fe(lll)·l (2:1) 0.28 190 
Fe(lll)·8-quinolinol 0.27' 310 
FcCI 1 0.31 
0.56" 
Cu(N0,),-3H,O 0.20' 
0.04' 
HU NRb·" 
> -0.2' 
DOC NR• 
a 100m V,/s, metal concentration (0.5 mM) unless otherwise indicated, TEAP (0.1 M), 
platinum flag versus SCE, adjusted to NHE, DMF unless otherwise indicated 
0Ethanol/DMF (75/25), 0.05 mM TEAP, single determination 
'50% aqueous ethanol, irreversible, EPP 2 value 
dJrreversible; Erp.? value 
<NR: no reduction 
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hibited the reaction. Other relevant observations 
include methemoglobin formation, sensitivity to 
oxidant stress, and blockage of DNA synthesis 
similar to that induced by X-rays (Przybys-
zewski & Malec, 1987). 
Diethyldithiocarhamate Diethyldithiocarbamate 
(DOC) exhibits anti-cancer properties (Spath & 
Tempel, 1987). Since dithiocarbamates are 
known to form metal chelates (Manoussakis & 
Bolos, 1985; Amatore eta/., 1988; Trombetta et 
a/., 1988), one can plausibly consider these deri-
vatives as the active agents. The redox charac-
teristics of the iron(Ill)·DDC (1:1) solution are 
given in Table III. This ratio was chosen because 
saturation of the metal with ligand nullifies the 
toxic effects of the chelate (Spath & Tempel, 
1987); presumably, open positions are needed 
for site binding. The ferric solution gave reduc-
tion at -0.20V (£,12 = 70mV), coupled to a 
small wave at 0.16 V. The large wave separation 
and reduced height of the oxidation portion may 
be due to dissociation of the complex after 
reduction; prior workers have observed such 
effects (Toropova et a/., 1978). Complexation 
with iron(III) resulted in a decrease of approxi-
mately 500 m V in the reduction potential of the 
metal. In another control experiment, the ligand 
gave no reaction before the background. The 
cupric complex reduced at - 0.49 V in a process 
that was 91% reversible with 6£, of lOOmV. 
Related electroanalytical studies of metal che-
lates (1:2) have been reported (Hendrickson et 
a/., 1976; Toropova et a/., 1978); an alcoholic 
benzene solution of the copper coordination 
compound reduced at -0.30 V (Cordova eta/., 
1977). 
Data suggest that cytotoxicity is peroxidative 
with involvement of copper (Trombetta et a/., 
1988). Inhibition by glutathione was observed. 
Strong copper chelators reduced the toxicity. 
The anti-tumor activity of DDC is increased by 
hyperbaric oxygen (Petrovskii eta/., 1982). The 
Cu· DOC compound is highly toxic to algae, 
apparently due to participation of Fenton 
chemistry with formation of hydroxyl radicals 
(Florence et a/., 1983). Involvement of super-
oxide has been suggested for the initial toxicity 
of this complex (Spath & Tempel, 1987). 
Alternatively, DOC has been proposed to inhi-
bit SOD (Lin eta/., 1979; Forman eta/., 1980; 
"~"'" " oi., ""'l· ""' i~ ,;,, '""ro'i"' 1 
unchecked, which may explain the potentiation 
of bleomycin toxicity (Lin et a/., 1980). It also 
inhibits lipid peroxidation (Freund! eta/., 198la 
and b; Younes eta/., 1984), but has no dismutat-
ing activity (Lengfelder, 1979). 
The dimethyl analog is a potent fungicide, but 
only in complex (copper) form (Albert, 1979a). 
Concentration quenching is evident. Oxidative 
destruction of lipoic acid is believed to be the 
molecular mode of action. 
8-Hydroxyquino/ine derivatives The bt:< deriva-
tive 1 of 8-hydroxyquinoline which readily che-
lates metals was found to have high activity 
against leukemia P388 (Yamato et a/., 1987). 
The action is attributed to complexation with 
the iron of ribonucleotide reductase which cata-
lyses DNA biosynthetic pathways. Recently, we 
proposed that several agents, (P-lactams, 
(Kovacic et a/., 1987; Kovacic et a/., 1988c), 
methotrexate and u-difluoromethylornithine 
(Kovacic et a/., 1988f)) which are thought to 
exert their activity solely by enzyme inactiva-
tion, may also be involved in electron transport. 
In this context, we carried out electrochemical 
studies on the Fe(Ill)-1 complex (2: 1); some 
isomer may be present (see the experimental 
section). Reduction occurred quasi-reversibly at 
0.28 V with i,./i of0.89 and 6£, of 190 mV in 
DMF (Table nl'), similar to Fe(Ill)·8-quinolinol 
(1:1): £ 1 = 0.27V, 6£, = 310mV, i,)ir< = 
0.87. The corresponding aqueous system was 
not examined due to reduced solubility of 1. 
AH3 
HOy OH CHU) 
,PI'<: 
;:,._ Q 
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The physiological (anti-bacterial) effects of 8-
bydroxyquinoline likely arise from the genera-
tion of metal compounds (Ames et a/., 1986b; 
Shterev & Kaneti, 1986). Metal coordination 
01ay be involved in the anti-cancer properties of 
streptonigrin in the 8-quinolinol form (Boger et 
a/., 1987). Various 8-hydroxyquinoline com-
plexes of Fe(III) accelerate lipid peroxidation 
(Hayakawa et a/., 1982) which is prevented by 
antioxidants (Ohtsuka et al., 1982). Oxy radical 
generation has been shown for l;>oth endogenous 
and exogenous compounds of iron and copper 
(Ames eta/., 1986b). 
The tropolone analogs of 1 also exhibit anti-
tumor activity, possibly due to metal chelation 
(Yamato eta/., 1987). 
Other considerations 
In response to the question concerning the 
actual form of the active metal species, there are 
several possibilities. Generally, binding to DNA 
appears to take place. In one case, the drug 
itself, e.g. Cu·phen, (Sigman, 1986), attaches to 
the surface and functions as such. This category 
encompasses the most stable complexes. The 
other class includes the chelates that are more 
prone to dissociation, namely, bis(acetato)his 
(imidazole)Cu(II), ruthenium ammine com-
plexes (Clarke eta/., 1986), and cis-DDP (Kova-
cic eta/., 1986). Fixation to the active site entails 
coordination to a ligand in DNA. In the 
exchange process, ligands from amino or thiol 
groups of protein could also become involved. 
Presumably, binding to DNA is followed by 
induction of ET at a sensitive locale. 
A number of correlations between reduction 
potential and activity have been noted for bipy, 
phen, DDC and 1 (see above). Prior work 
(Kovacic eta/., 1986; Crawford eta/., 1987) has 
revealed a similar relationship for cis- versus 
trans-DDP, and for Cu- versus Ni-salicylaldoxi-
mate. Apparently, the metal plays a primary 
role since removal results in decreased toxicity 
(Trombetta et a/., 1988). Absolute interrelation 
between in vitro electrochemical behavior and 
physiological activity is not reasonable due to 
important involvement of other variables, such 
as metabolism, diffusion, solubility (Florence et 
al., 1983; Florence & Stauber, 1986; Trombetta 
eta/., 1988), site binding, and stereochemistry. 
Some of the complexing agents treated in this 
work show activities in other areas, e.g. bipy or 
phen, anthelmintic (Albert, 1979a), antibacterial 
(Shulman et a/., 1972), DDC, antifungal, and 
antimycobacterial (Albert, 1979a) which may be 
related to ET reactions (Ames et a/., 1986b; 
Kovacic et a/., 1988d). 
Application of the general theme has also 
been made to ~-lactam antibiotics (Kovacic et 
a/., 1987b; Kovacic et a/., 1988c), cocaine 
(Kovacic et a/., 1988e), antiprotozoan agents 
(Ames eta/., 1987b), anthclmintics (Kovacic et 
a/., 1988d), and amebicides (Ames eta/., 1987a). 
References to other areas investigated (benzo-
diazepines, 1-methyl-4-phenyl-1 ,2,3,6-tetra-
hydropyridine, mesoionic compounds, carcino-
gens, phencyclidine, nicotine, spermine, and 
antibacterial agents) are given elsewhere (Ames 
eta/., 1986b; Crawford eta/., 1986; Ames et a/., 
1987a and b). Redox cycling involving electron 
transfer is increasingly implicated in the 
mechanism of action of various drugs, and has 
been reviewed (Halliwell & Gutteridge, 1985; 
Kappus, 1986). 
In summary, various steps seem to be 
involved in the physiological activity. Site bind-
ing occurs, frequently involving DNA (Basile & 
Barton, 1987). As a result, there could be inter-
ference with DNA replication or other essential 
processes. Our electrochemical evidence 
suggests the participation of ET. Redox cycling 
can generate toxic oxy radicals or interfere with 
normal electron transport. DNA binding might 
favor reversibility and an increased reduction 
potential (Ames et a/., 1986c; Crawford et a/., 
I 986; Carter & Bard, 1987). 
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